Changing the traditional healthcare model and moving from cure to prevention will take time.
Companies will soon be able to capitalize on the government’s push to encourage investment in private healthcare facilities.
Without financial incentives, pediatric device development won’t get the attention that it needs.
Using infrared light therapy, this compact device triggers regeneration and natural healing at a low price point.
Not surprisingly, data science will reign over blockbuster drugs or devices.
The Senate vote is good news for industry, which has fought against the tax for years.
The company will invest €13 million in the facility, which will make drug-coated balloons for peripheral artery disease.
In lieu of trials, some companies may be able to submit a CER.
Trends in mHealth to be driven by increased smartphone penetration and prevalence of chronic diseases.
Industry consolidation, consumerized medical devices and cybersecurity are the top issues in the year ahead.